secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001628280-24-005673
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q4 revenue falls 43% to $191M; guides Q1 2024 revenue $155-175M
------------------------------------------------------------------------

- Q4 net income $6.0M ($0.55 diluted EPS); adjusted net income $11.9M ($1.09 adjusted EPS).
- Active OPTA VIA Coaches down 32.5% YoY to 41,100; revenue per coach fell 16.1% to $4,648.
- Full-year 2023 revenue $1.1B, down 32.9% YoY; net income $99.4M ($9.10 diluted EPS).
- Q1 2024 revenue guidance $155-175M; diluted EPS $0.25-0.95, excluding LifeMD collaboration costs.
- Cash and investments $150M, no interest-bearing debt; company pivoting to medically-supported weight loss with LifeMD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828024005673/0001628280-24-005673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828024005673/med-20240220.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-005673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer